{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:45:39Z","timestamp":1791395139020,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.nano.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T01:45:47Z","timestamp":1393897547000},"page":"1311-1321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Poly(lactic acid)\u2013poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice"],"prefix":"10.1016","volume":"10","author":[{"given":"Saurabh","family":"Dixit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree R.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebayehu N.","family":"Yilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Ronald D.","family":"Agee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtada","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida A.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2014.02.009_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2009.09.001","article-title":"Biodegradable polymeric nanoparticles based drug delivery systems","volume":"75","author":"Kumari","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2014.02.009_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.009_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2006.05.018","article-title":"Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity","volume":"40","author":"Kalkanidis","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.nano.2014.02.009_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.vetpar.2011.05.028","article-title":"Nanomedicine: novel approaches in human and veterinary therapeutics","volume":"180","author":"Irache","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.nano.2014.02.009_bb0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2009.10.025","article-title":"Preparation and characterization of a nanoparticulate formulation composed of PEG\u2013PLA and PLA as anti-inflammatory agents","volume":"385","author":"Ishihara","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.009_bb0030","doi-asserted-by":"crossref","first-page":"474605","DOI":"10.1155\/2012\/474605","article-title":"Nanoparticulate adjuvants and delivery systems for allergen immunotherapy","volume":"2012","author":"De Souza Rebou\u00e7as","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.nano.2014.02.009_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02652048.2012.714410","article-title":"Improved antifungal activity of itraconazole-loaded PEG\/PLA nanoparticles","volume":"30","author":"Essa","year":"2013","journal-title":"J Microencapsul"},{"key":"10.1016\/j.nano.2014.02.009_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2009.02.010","article-title":"Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B","volume":"136","author":"Jain","year":"2009","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.009_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/sextrans-2011-050223","article-title":"It matters what you measure: a systematic literature review examining whether young people in poorer socioeconomic circumstances are more at risk of chlamydia","volume":"89","author":"Sheringham","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.nano.2014.02.009_bb0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/mi.2007.19","article-title":"Chlamydia trachomatis infection: host immune responses and potential vaccines","volume":"1","author":"Hafner","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nano.2014.02.009_bb0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.vaccine.2005.08.097","article-title":"Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2014.02.009_bb0060","doi-asserted-by":"crossref","first-page":"e5409","DOI":"10.1371\/journal.pone.0005409","article-title":"A vault nanoparticle vaccine induces protective mucosal immunity","volume":"4","author":"Champion","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2014.02.009_bb0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","article-title":"Nanotechnology in vaccine delivery","volume":"60","author":"Peek","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.02.009_bb0070","first-page":"738","article-title":"Nanoparticulate systems and other novel approaches in the diagnosis, prevention and treatment of HIV\/AIDS","volume":"2","author":"Sandhya","year":"2010","journal-title":"Int J Pharm Sci"},{"key":"10.1016\/j.nano.2014.02.009_bb0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4236\/wjv.2011.14014","article-title":"A peptide containing T-cell epitopes of Chlamydia trachomatis recombinant MOMP induces systemic and mucosal antibody responses in mice","volume":"1","author":"Taha","year":"2011","journal-title":"WJV"},{"key":"10.1016\/j.nano.2014.02.009_bb0080","doi-asserted-by":"crossref","first-page":"325101","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA 85\/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2014.02.009_bb0085","first-page":"2085","article-title":"Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper-1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.009_bb0090","first-page":"1759","article-title":"Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles","volume":"8","author":"Cambridge","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.009_bb0095","first-page":"2421","article-title":"Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatis","volume":"8","author":"Yilma","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.009_bb0100","doi-asserted-by":"crossref","first-page":"e43860","DOI":"10.1371\/journal.pone.0043860","article-title":"Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice","volume":"7","author":"Gautam","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2014.02.009_bb0105","doi-asserted-by":"crossref","first-page":"102457","DOI":"10.1155\/2013\/102457","article-title":"Flavonoid naringenin: a potential immunomodulator for Chlamydia trachomatis inflammation","volume":"2013","author":"Yilma","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nano.2014.02.009_bb0110","doi-asserted-by":"crossref","first-page":"520174","DOI":"10.1155\/2012\/520174","article-title":"The anti-inflammatory cytokine, interleukin-10, inhibits inflammatory mediators in human epithelial cells and mouse macrophages exposed to live and UV-inactivated Chlamydia trachomatis","volume":"2012","author":"Yilma","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nano.2014.02.009_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2003.12.021","article-title":"Self-porating polymersomes of PEG\u2013PLA and PEG\u2013PCL: hydrolysis-triggered controlled release vesicles","volume":"96","author":"Ahmed","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.009_bb0120","first-page":"35","article-title":"Delivery of tumor antigens to dendritic cells using biodegradable microspheres","volume":"109","author":"Waeckerle-Men","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.nano.2014.02.009_bb0125","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1208\/s12249-008-9148-3","article-title":"Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances","volume":"9","author":"Wu","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2014.02.009_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2014.02.009_bb0135","first-page":"1057","article-title":"Recent advances in PEG\u2013PLA block copolymer nanoparticles","volume":"5","author":"Xiao","year":"2010","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.009_bb0140","first-page":"1443","article-title":"Novel PEG\u2013graft\u2013PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium","volume":"6","author":"Wang","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2014.02.009_bb0145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.matlet.2010.01.076","article-title":"PEG\u2013PLA nanoparticles prepared by emulsion solvent diffusion using oil-soluble and water-soluble PEG\u2013PLA","volume":"64","author":"Makoto","year":"2010","journal-title":"Mater Lett"},{"key":"10.1016\/j.nano.2014.02.009_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","article-title":"Design of biodegradable particles for protein delivery","volume":"78","author":"Vila","year":"2002","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.02.009_bb0155","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.biomaterials.2006.03.039","article-title":"Parameters influencing the stealthiness of colloidal drug delivery systems","volume":"27","author":"Vonarbourg","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.02.009_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(94)90092-2","article-title":"Biodegradable microspheres as controlled-release tetanus toxoid delivery systems","volume":"12","author":"Alonso","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2014.02.009_bb0165","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijpharm.2010.05.020","article-title":"Intranasal delivery of zidovudine by PLA and PLA\u2013PEG blend nanoparticles","volume":"395","author":"Mainardes","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2014.02.009_bb0170","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2014.02.009_bb0175","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.181.7.4955","article-title":"Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice","volume":"181","author":"Forbes","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2014.02.009_bb0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1574-695X.2009.00536.x","article-title":"Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics","volume":"55","author":"Morr\u00e9","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.nano.2014.02.009_bb0185","doi-asserted-by":"crossref","first-page":"e2020","DOI":"10.1371\/journal.pntd.0002020","article-title":"Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis","volume":"7","author":"Hu","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nano.2014.02.009_bb0190","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4161\/hv.6.8.12299","article-title":"Development of a Chlamydia trachomatis T-cell vaccine","volume":"6","author":"Karunakaran","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.nano.2014.02.009_bb0195","doi-asserted-by":"crossref","first-page":"e39214","DOI":"10.1371\/journal.pone.0039214","article-title":"IL-17A synergizes with IFN-\u03b3 to upregulate iNOS and NO production and inhibit chlamydial growth","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2014.02.009_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nano.2014.02.009_bb0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/mi.2010.58","article-title":"CXCR3 and CCR5 are both required for T-cell-mediated protection against Chlamydia trachomatis infection in the murine genital mucosa","volume":"4","author":"Olive","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.nano.2014.02.009_bb0210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/1566524054863906","article-title":"Induction of anti-chlamydial mucosal immunity by transcutaneous immunization is enhanced by topical application of GM-CSF","volume":"5","author":"Hickey","year":"2005","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.nano.2014.02.009_bb0215","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.4049\/jimmunol.169.11.6324","article-title":"GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis","volume":"169","author":"Lu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2014.02.009_bb0220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2014.02.009_bb0225","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2014.02.009_bb0230","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2014.02.009_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0264-410X(97)00206-5","article-title":"Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge","volume":"15","author":"Pal","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2014.02.009_bb0240","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/IAI.65.7.2693-2699.1997","article-title":"Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection","volume":"65","author":"Peterson","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2014.02.009_bb0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.01062-12","article-title":"Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis","volume":"81","author":"Massari","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.nano.2014.02.009_bb0250","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1128\/IAI.00611-08","article-title":"Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice","volume":"77","author":"Chen","year":"2009","journal-title":"Infect Immun"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T20:08:47Z","timestamp":1597522127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1549963414000446"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2014.02.009","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poly(lactic acid)\u2013poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}